Molecular evolution of oral poliovirus vaccine strains during multiplication in humans and possible implications for global eradication of poliovirus

Acta Virologica

Volumn 44, Issue 2, 2000, Pages 109-117

  Friedrich, F ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Deletion; Mutation; Oral poliovirus vaccine; Poliomyelitis; Poliomyelitis eradication; Poliovirus; Recombination; Vaccine derived polioviruses

Indexed keywords

ORAL POLIOMYELITIS VACCINE;

ARTICLE; DNA MODIFICATION; DRUG EXCRETION; ERADICATION THERAPY; GENE DELETION; GENE MUTATION; GENETIC RECOMBINATION; HUMAN; MOLECULAR EVOLUTION; NONHUMAN; PARALYSIS; PERSISTENT INFECTION; POLIOMYELITIS; VACCINATION; VIROGENESIS; VIRUS ATTENUATION; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS VIRULENCE;

ANIMALS; ENVIRONMENT; EVOLUTION, MOLECULAR; GENOME, VIRAL; HUMANS; NERVOUS SYSTEM DISEASES; PARALYSIS; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL; VIRUS REPLICATION; WORLD HEALTH;

POLIOVIRUS;

EID: 0033856290     PISSN: 0001723X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (76)

1. Shedding of virulent poliovirus revertants during immunization with oral poliovirus vaccine after prior immunization with inactivated polio vaccine
2. Recombination and other genomic rearrangements in picornaviruses
3. Paralytic poliomyelitis in a contact of a vaccinated child
4. Vaccine-associated poliomyelitis in a contact
5. Vaccine related poliomyelitis in non-immunised relatives and household contacts
6. Evolution of poliovirus type 1 during 5.5 years of prolonged enteral replication in an immunodeficient patient
7. Precise missense and silent point mutations are fixed in the genomes of poliovirus mutants from persistently infected cells
8. Direct detection of Sabin poliovirus vaccine strains in stool specimens of first dose vaccinees by a sensitive reverse transcription PCR method
9. Vaccine-associated paralytic poliomyelitis
10. Intertypic genomic rearrangements of poliovirus strains in vaccinees
11. Reversion to neurovirulence of the live-attenuated Sabin type 3 oral poliovirus vaccine
12. Paralytic poliomyelitis in an unimmunized child
13. Genetic stability of oral polio vaccine prepared on primary monkey kidney cells or Vero cells - Effects of passage in cell culture and the human gastrointestinal tract
14. Paralytic poliomyelitis associated with live oral poliomyelitis vaccine in a child with HIV infection in Zimbabwe: Case report
15. An appproach to understanding the mechanisms of poliovirus persistence in infected cells of neural or nonneural origion
16. Genetic characterization of Sabin types 1 and 3 poliovaccine virus following serial passage in the human intestinal tract
17. Acute infantile weakness: A case of vaccine-associated poliomyelitis
18. Surveillance of suspected poliomyelitis in Albania, 1980-1995: Suggestion of increased risk of vaccine associated poliomyelitis
19. Genomic characterization of human and environmental polioviruses isolated in Albania
20. Poliomyelitis eradication
21. Vaccine-associated cases of poliomyelitis over a 30 year period in East Germany
22. Australia's contribution to global polio eradication initiatives
23. Virus excretion and mutation by infants following primary vaccination with live oral poliovaccine from two sources
24. Die Persistenz des Impfvirus beim Guillain-Barre-Syndrome im Gefolge der Polioschluckimpfung als diagnostischer Hinweis
25. Identification of a consistent pattern of mutations in neurovirulent variants derived from the Sabin vaccine strain of poliovirus type 2
26. Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome
27. Antigenic and biochemical characterization of poliovirus type 2 isolated from two cases of paralytic disease
28. Vaccine-associated paralytic poliomyelitis
29. Genomic characterization of type 2 polioviruses isolated from vaccine-associated cases in Brazil
30. Genomic characterization of type 3 polioviruses isolated from vaccine-associated poliomyelitis cases in Brazil
31. Genomic characterization of type 1 Sabin-related polioviruses isolated in Brazil
32. Type 2 poliovirus recombinants isolated from vaccine-associated cases and from healthy contacts in Brazil
33. Poliovirus type 1 isolated from a vaccine-associated case of paralytic poliomyelitis in Brazil
34. Rare adverse events associated with oral poliovirus vaccine in Brazil
35. Polioviruses with natural recombinant genomes isolated from vaccine-associated paralytic poliomyelitis
36. High diversity of poliovirus strains isolated from the central nervous system from patients with vaccine-associated paralytic poliomyelitis
37. Tripartite genome organization of a natural type 2 vaccine/ nonvaccine recombinant poliovirus
38. Mapping of mutations contributing to the temperature sensitivity of the Sabin 1 vaccine strain of poliovirus
39. Evolution of the Sabin type 1 poliovirus in humans: Characterization Of strains isolated from patients with vaccine-associated paralytic poliomyelitis
40. Random selection: A model for poliovirus infection of the central nervous system
41. Point mutations involved in the attenuation/neurovirulence alternation in type 1 and 2 oral polio vaccine strains detected by site-specific polymerase chain reaction
42. Vaccine-associated poliovirus meningites in children with ventriculoperitoneal shunts
43. Postpolio syndrome: Poliovirus persistence is involved in the pathogenesis
44. Multiple genetic changes can occur in the oral poliovaccines upon replication in humans
45. Prolonged replication of a type 1 vaccine-derived poliovirus in an immuno-deficient patient
46. Ending polio immunization: When and how are we sure that the needle is out of the haystack?
47. Detection of poliovirus antibodies and poliovirus genome in patients with the post-polio syndrome
48. Evidence of presence of poliovirus genomic sequences in cerebrospinal fluid from patients with postpolio syndrome
49. Genetic basis of the neurovirulence of type 1 polioviruses isolated from vaccine-associated paralytic patients
50. Frequent isolation of intertypic poliovirus recombinants with serotype 2 specificity from vaccine-associated polio cases
51. Persistent infection of human erythroblastoid cells by poliovirus
52. Reversion of the attenuated and temperature-sensitive phenotypes of the Sabin type 3 strain of poliovirus in vaccinees
53. The 5' noncoding region of the type 2 poliovirus vaccine strain contains determinants of attenuation and temperature sensitivity
54. Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates
55. Comparative study of poliovirus excretion after vaccination of infants with two oral polio vaccines prepared on Vero cells or on primary monkey kidney cells
56. Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion by a primary vaccinee
57. The effect of sequences in the 5' noncoding region on the replication of polioviruses in the human gut
58. The temperature sensitivity of the Sabin type 3 vaccine strain of poliovirus: Molecular and structural effects of a mutation in the capsid protein VP3
59. Vaccine-aquired paralytic poliomyelitis in an unvaccinated mother
60. A Sabin vaccine-derived field isolate of poliovirus type 1 displaying aberrant phenotypic and genetic features, including a deletion in antigenic site 1
61. Molecular analysis of poliovirus 3 isolated from an aerosol genereted by a waste water treatment plant
62. Molecular and biological characterization of poliovirus 3 strains isolated in Adriatic seawater samples
63. Coupled mutations in the 5'-untranslated region of the Sabin poliovirus strains during in vivo passages: Structural and functional implications
64. Effect of prior immunity on the shedding of virulent revertant virus in feces after oral immunization with live attenuated poliovirus vaccines
65. Genomic modifications in naturally occurring neurovirulent revertants of Sabin 1 polioviruses
66. Persistent poliovirus infection of human fetal brain cells
67. Characterization of persistent poliovirus mutants selected in human neuroblastoma cells
68. One amino acid change on the capsid surface of poliovirus Sabin 1 allows the establishment of persistent infections in Hep-2 cell cultures
69. Nucleotide sequence of a neurovirulent variant of the type 2 oral poliovirus vaccine
70. Genetic basis for immunological aberrations in poliovirus Sabin serotype 3 strains imported in the Netherlands
71. Poliomyelitis associated with type 2 virus
72. Oral poliovirus vaccine in the United States: Molecular characterization of Sabin type 3 after replication in the gut of vaccinees
73. Genetics of poliovirus
74. Alteration in oligonucleotide fingerprint patterns of the viral genome in poliovirus type 2 isolated from paralytic patients
75. Surveillance of poliovirus-isolates in Japan, 1998
76. An infant with encephalitis